The Use of Glial Fibrillary Acidic Protein in First-Tier Assessments of Neurotoxicity

Abstract

Diverse neurotoxic insults result in proliferation and hypertrophy of astrocytes, a subtype of central nervous system glia. The hallmark of this response, often termed “reactive gliosis,” is the enhanced expression of the major intermediate filament protein of astrocytes, glial fibrillary acidic protein (GFAP). These morphological observations suggest that GFAP may be a useful biochemical indicator of neurotoxicity. To investigate this possibility we have administered prototype neurotoxicants to experimental animals and then assessed the effects of these agents on the tissue content of GFAP, as determined by radioimmunoassay. We found that assays of GFAP reveal dose-, time-, and region-dependent patterns of neurotoxicity at toxicant dosages below those that cause light microscopic evidence of cell loss or damage. No false positives have been seen following exposure to a variety of pharmacological agents. By using regional assessments of GFAP in a first-tier evaluation, it should be possible to localize areas of damage. A second-tier evaluation, using assays of proteins or transmitters associated with cells in the affected region, may reveal the cellular targets of neurotoxicity. This two-tiered approach should serve as a foundation for guiding studies aimed at determining mechanisms of neurotoxicity.

References

1. O'Callaghan, J.P. (1991). Assessment of neurotoxicity: Use of glial fibrillary acidic protein as a biomarker. Biomed. Environ. Sci. 4, 197–206.

2. Duffy, P.E. (1983). Astrocytes: Normal, Reactive and Neoplastic. New York: Raven Press.

3. Lindsay, R.M. (1986). Reactive gliosis. In: Fedoroff, S. and Vernadakis, A. , eds. Astrocytes: Cell Biology and Pathology of Astrocytes, Vol. 3. Orlando, FL: Academic Press, pp. 231–262.

4. Reier, P.J. (1986). Gliosis following CNS injury: the anatomy of astrocyctic scars and their influences on axonal elongation. In: Fedoroff, S. and Vernadakis, A. , eds., Astrocytes: Cell Biology and Pathology of Astrocytes, Vol. 3. Orlando, FL: Academic Press, pp. 263–324.

5. Eng, L.F. (1987). Experimental models for astrocyte activation and fibrous gliosis. In: Althaus, H.H. and Seifert, W. , eds. Glial-Neuronal Communication in Development and Regeneration. Heidelberg: Springer Verlag, pp. 27–40.

6. Eng, L.F. (1988). Regulation of glial intermediate filaments in astrogliosis. In: Norenberg, M.D. , Hertz, L. , and Schousboe, A. , eds. Biochemical Pathology of Astrocytes. New York: Allen R. Liss, pp. 79–90.

7. O'Callaghan, J.P. (1988). Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity, Neurotoxicol. Teratol. 10, 445–452.

8. O'Callaghan, J.P. and Miller, D.B. (1989). Assessment of chemically-induced alterations in brain development using assays of neuron- and glia-localized proteins. Neurotoxicol, 10, 393–406.

9. O'Callaghan, J.P. and Miller, D.B. (1983). Nervous-system specific proteins as biochemical indicators of neurotoxicity. Trends Pharmacol. Sci. 4, 388–390.

10.

10. Brock, T.O. and O'Callaghan, J.P. (1987). Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. J. Neurosci. 7, 931–942.

11.

11. O'Callaghan, J.P. and Miller, D.B. (1988). Acute exposure of the neonatal rat to triethyltin results in persistent changes in neurotypic and gliotypic proteins. J. Pharmacol. Exp. Ther. 244, 368–378.

12.

12. O'Callaghan, J.P. (1991). Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13, 275–281.

13.

13. O'Callaghan, J.P. (1991). Neurotypic and gliotypic proteins as biochemical indicators of neurotoxicity. In: Abou-Donia, MB. ed. Textbook on Neurotoxicology. Boca Raton: CRC Press.

14.

14. O'Callaghan, J.P. , Miller, D.B. , and Reinhard, J.F. , Jr. (1990). Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, l-methyl-4-phenyl-l, 2,3,6-tetrahydropyridine. Brain Res. 521, 73–80.

15.

15. O'Callaghan, J.P. , Miller, D.B. , and Reinhard, J.F. , Jr. (1990). MPTP-induced loss of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP. Neurosci. Lett. 117, 228–233.

16.

16. Mathewson, A.J. and Berry, M. (1985). Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res. 327, 61–69.

17.

17. Balaban, C.D. , O'Callaghan, J.P. , and Billingsley, M.L. (1988). Trimethyltin-induced neuronal damage in the rat brain: Comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 26, 337–361.

18.

18. Jensen, K.F. , Miller, D.B. , O'Callaghan, J.P. , and Reinhard, J.F. Jr., (1989). Immunohistochemical characterization of MPTP induced degeneration in striatum and substantia nigra of C57 mice. Soc. Neurosci. Abstr. 15, Part 2, 1011.